MERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times ...

We base our valuation on a dividend discount model using a 7.5% cost of equity. Transurban is arguably a long-term, inflation-linked, amortizing bond, with growth options. EBITDA margin is high, at ...

Gideon Rachman, chief foreign affairs commentator at the Financial Times, wrote in an article published Monday that President ...

Palantir shares hit a record high for the second straight day on Monday, as the AI-powered analytics software provider ...

Musk appears eager to refocus on his array of businesses after announcing last week that he would be stepping back from ...

More private hospitals will face similar financial troubles and some will be forced to close. Here’s what this means for ...

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

Recent stock market volatility has many Americans worried for their retirement funds. Entrepreneur and millionaire real ...

Increased use of “buy now, pay later” loans may signal shifting consumer habits, but could also be a troubling sign of ...

A Ukrainian drone swarm costing thousands of dollars appears to have caused billions in damage—just as Trump advances a $175 ...

Trump said that U.S. steel and aluminum tariffs will increase starting on June 4, in what he labeled as a jolt to domestic ...

Like most major U.S. cities, Denver has experienced its financial ups and downs over the past decade. Nevertheless, a look ...